TABLE 2

Patients with discordant outcome (more details in supplementary table S1)

Patient number (lab ID)Age at referral yearsSexClinical featuresnNO nL·min-1#HSVM fresh (more details in supplementary table S1)HSVM ALI (more details in supplementary table S1)IFTEM BEAT-PCD-TEM [12] classificationGenetics ACMG-classification [27]Costsf EUROutcome ATSOutcome ERSOutcome PCD-UNIBEMain tools leading to diagnosis
4 (272)6.6MBronchiectasis
Chronic wet cough
Sister with similar
symptoms
175No evidence for PCDNo evidence for PCDDNAH9 missing (ALI)ODA & IDA Defect <50% (ALI)
class 2 defect, PCD likely
Two DNAH9 variants in-cis, non-diagnostic5908PCD not diagnosed
nNO normal
Genetics non-diagnostic
No hallmark TEM defect
PCD highly unlikely
No hallmark TEM defect
Genetics of unknown significance
PCD highly likely
Class 2 TEM defect
IF with DNAH9 missing
Clinics
TEM
cell culture
IF
9 (323)65.1MBronchiectasis
Chronic wet cough
Recurrent respiratory tract
infections
14High evidence for PCDInconclusiveDNAH9 repeatedly completely missing (ALI)Non-diagnosticNo likely pathogenic or pathogenic variant found in 42 genes tested (2020)6908PCD diagnosed
Suggestive clinics
nNO low (single measurement)
PCD highly unlikely
nNO low
HSVM inconclusive
TEM non-diagnostic
Genetics negative
PCD highly likely
nNO low
HSVM inconclusive
IF with DNAH9 missing
nNO
cell culture
IF
14 (361)23.6FChronic productive cough
Chronic rhinitis
152InconclusiveHigh evidence for PCDAll proteins presentNon-diagnostic (fresh)Refused by patient3855PCD not diagnosed
nNO normal
TEM non-diagnostic
(genetics to be done)
PCD highly likely
HSVM repeatedly suggestive
PCD highly likely
HSVM suggestive
HSVM
cell culture
15 (253)9.2mPICADAR 6
chronic wet cough
Chronic rhinitis
Cardiac malformation (pulmonary & tricuspid atresia)
Recurrent otitis media
Immune deficiency
20
9+
No evidence for PCDNo evidence for PCDAll proteins present--1908PCD diagnosed
Suggestive clinics
nNO repeatedly low
PCD highly unlikely
HSVM fresh & ALI normal
PCD highly unlikely
HSVM fresh & ALI normal
IF without protein missing
nNO
16 (285)15.6mChronic purulent cough
Chronic rhinitis
Premature birth
Obstructive sleep apnoea
7.5§
7
PCD likelyNo evidence for PCDDNAH9 inconclusive (ALI)
inconclusive
Non-diagnostic (ALI)No likely pathogenic or pathogenic variant found in 43 genes tested (2020)6249PCD diagnosed
Suggestive clinics
nNO repeatedly low
PCD highly unlikely
HSVM ALI normal
TEM non-diagnostic
Genetics negative
PCD highly unlikely
HSVM ALI normal
TEM non-diagnostic
Genetics negative
nNO
17 (294)5.0fChronic wet cough
Recurrent respiratory tract
infections
Bronchiectasis
11
12
No evidence for PCDNo evidence for PCDNo evidence for PCD-No likely pathogenic or pathogenic variant found in 41 genes tested (2019)4930PCD diagnosed
Suggestive clinics
nNO repeatedly low
PCD highly unlikely
HSVM normal
Genetics negative
PCD highly unlikely
HSVM normal
IF without protein missing
Genetics negative
nNO
18 (295)5.1fChronic cough
Recurrent respiratory
tract infections
Recurrent otitis media
5InconclusiveNo evidence for PCDAll proteins present--1877PCD diagnosed
Suggestive clinics
nNO low (single measurement)
PCD highly unlikely
HSVM normal
PCD highly unlikely
HSVM normal
IF without protein missing
nNO
19 (319)6.5mPremature birth
NRDS & intensive care admittance
Chronic rhinitis
Chronic cough
Recurrent bronchitis
Bronchopulmonary dysplasia
OSAS
6.5§
41
No evidence for PCDInconclusiveNo evidence for PCDNon-diagnostic (ALI)No likely pathogenic or pathogenic variant associated with PCD found in 6688 genes tested (2020)5855PCD diagnosed
Suggestive clinics
nNO repeatedly low
PCD highly unlikely
HSVM normal
TEM non-diagnostic
PCD highly unlikely
HSVM normal
TEM non-diagnostic
IF without protein missing
nNO

Single discordant outcome highlighted in italic letters. Bold text indicates results leading to a diagnosis of PCD and the final diagnosis. ACMG: American College of Medical Genetics and Genomics; ALI: air–liquid interface; ATS: American Thoracic Society; Array-CGH: array-based comparative genomic hybridisation; ERS: European Respiratory Society; f: female; HSVM: high-speed videomicroscopy; IDA: inner dynein arm; IF: immunofluorescence labelling; m: male; nNO: nasal nitric oxide; NRDS: neonatal respiratory distress syndrome; ODA: outer dynein arm; PCD: primary ciliary dyskinesia; PCD-UNIBE: comprehensive diagnostic centre at the University Children's Hospital, Inselspital Bern, Switzerland; TEM: transmission electron microscopy. #: these are mean values for nNO for the right and left side. The unit for nNO results at our centre is parts per billion (ppb). To obtain values in nL·min-1 the formula (ppb) × sampling flow rate (0.33 mL·min-1 for Ecomedics Analyzer CLD 88 sp) was used as proposed in Leigh et al. [18]. : single nNO measurement. +: cystic fibrosis not excluded by sweat test or genetic testing. §: nNO measurement during rhinitis. f: remark about the costs: the costs were estimated based on costs that are billed for each method performed (for costs of each method see supplementary table S2 and figure S1). The costs may be higher than in other studies; however, we have to consider that prices and salaries are usually higher in Switzerland compared to other countries.